Z-0282-2021 Class II Terminated
FDA device recall Z-0282-2021 was initiated by Fujifilm Medical Systems U.S.A., Inc. on Sep 11, 2020 and is designated Class II. Reason for recall: FUJIFILM has become aware of the possibility that certain CT studies may report a much higher 3D Sphere MAX value than expected. This issue is specific to 3D Sphere - other density tools are not… The recall status is terminated (terminated Nov 17, 2021). Affected quantity: 1.
Recall details
- Product Type
- Devices
- Report Date
- Oct 28, 2020
- Initiation Date
- Sep 11, 2020
- Termination Date
- Nov 17, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1
Product description
Synapse PACS Software Version 5.6.1 - Product Usage: intended for use as a web based application on an off-the shelf PC which meets or exceeds minimum specifications and is networked with a FUJIFILM Synapse PACS server.
Reason for recall
FUJIFILM has become aware of the possibility that certain CT studies may report a much higher 3D Sphere MAX value than expected. This issue is specific to 3D Sphere - other density tools are not affected.
Distribution pattern
US Nationwide distribution including in the state of Minnesota.
Code information
Synapse Software Version 5.6.1
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0282-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026